Detalhe da pesquisa
1.
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).
Gynecol Oncol
; 178: 161-169, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890345
2.
Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.
Respir Res
; 23(1): 258, 2022 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127726
3.
Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.
Respir Res
; 19(1): 133, 2018 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30001712
4.
Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial.
Trials
; 25(1): 301, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702828
5.
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial.
JCO Precis Oncol
; 8: e2300693, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754056
6.
Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
Respir Med
; 119: 115-121, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27692131
7.
Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
J Aerosol Med Pulm Drug Deliv
; 28(6): 486-97, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26372467
8.
Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury.
Eur J Pain
; 15(10): 1040-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21576029